No such message found

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Free
Message: in-the-news
Reply New Message
Prev Message Back To Forum Threaded View Next Message

''Pluristem Therapeutics Inc. (PSTI) saw share prices soar to a morning session high of $3.85 on trading volume 2051.36 % higher than their daily average before pulling back with the overall markets. The Israeli biotech has been getting attention from analysts and financial bloggers. Investors have been accumulating shares at record pace during the last two sessions, spurred on by both recent and pending news developments.

http://finance.yahoo.com/news/healthcare-review-onyx-pharmaceuticals-gets-180202165.html''

e

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply